AIV Logo AIV Assistant

Loading...

 Logo Revenio Group Oyj - REG1V.HE Open Revenio Group Oyj in new tab

22.55 EUR
P/E
35.07
EPS
0.69
Yield
1.60%
P/B
5.90
ROE
17.60
Beta
1.43
Target Price
29.20 EUR

22.5500 EUR

22.550 EUR

Daily: +0.00%
Key Metrics

Earnings date: Feb. 11, 2026

P/E: 35.07

EPS: 0.69

Book Value: 4.10

Price to Book: 5.90

Debt/Equity: 11.56

% Insiders: 3.226%

Growth

Revenue Growth: 0.08%

Earnings Growth: 0.10%

Estimates

Forward P/E: 25.47

Forward EPS: 0.95

Target Mean Price: 29.20

Dividend

Dividend Yield: 1.60%

Annual dividends: 0.40 EUR

Ex-Div. Date: April 11, 2025

Payout: 58.60%

5y avg Yield: 1.00%

DCF Valuation

Tweak assumptions to recompute fair value for Revenio Group Oyj (REG1V.HE)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

 Logo About Revenio Group Oyj - (REG1V.HE)

Country: Finland

Sector: Health Care

Website: http://www.reveniogroup.fi

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for measuring IOP on animal patients by general veterinary practitioners, veterinary ophthalmologists and other veterinary medical personnel. It also provides imaging devices comprising iCare EIDON, a device with confocal retinal imaging; iCare DRSplus, a device for pupil imaging; and iCare COMPASS, which provides fundus perimetry with true-color confocal retinal images. In addition, the company offers iCare ILLUME, a screening software that helps to detect the early signs of diabetic retinopathy, age-related macular degeneration, and glaucoma using artificial intelligence; iCare CLINIC cloud software to store long-term IOP data; and Oculo, an eye care software platform, which combines clinical communication, telehealth, remote patient monitoring and data analytics capabilities. Revenio Group Oyj was incorporated in 2001 and is based in Vantaa, Finland.

Exchange Ticker
MUN (Germany) R0V.MU
HEL (Finland) REG1V.HE
Dividend Yield

1.60% (5y avg: 1.00%)

Annual Dividends

0.40 EUR

Next ex. div date

April 11, 2025

Payout Ratio

58.60%

Historical Dividends
Year Total Dividends
2026 0.42 EUR
2025 0.40 EUR
2024 0.38 EUR
2023 0.36 EUR
2022 0.34 EUR
2021 0.32 EUR
2020 0.30 EUR
2019 0.56 EUR
2018 1.56 EUR
2017 1.48 EUR
2016 1.40 EUR
2015 0.90 EUR
2014 0.60 EUR
2013 0.84 EUR
2012 0.00 EUR
2011 0.00 EUR
2010 0.00 EUR
2009 0.00 EUR
2008 0.01 EUR
2007 0.00 EUR

Yearly aggregated dividends

Dividends

Revenio Group Oyj
Apr 23, 2025 Paid
Dividend
0.4 EUR

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion